heart failure drugs Flashcards
drugs for HF
beta blockers, sacubitril-valsartan, loop diuretics, potassium sparing diuretics, hydralazine, isosorbide mononitrate/dinitrate, ivabradine, cardiac glycosides,
mechanism of loop diuretics
- selective inhibition of Na+/K+/2Cl- transporter in thicking ascending limb –> less K+ in urine –> greater excretion of Mg2+ and Ca2+
- greater excretion of Na+ and Cl- –> less driving force for water reabsorption
- induce renal PG synthesis
mechanism of potassium sparing diuretics
- inhibits aldosterone from binding to aldosterone receptor (spironolactone and eplereone) –> less Na+ and H2O reabsorption, less K+ secretion
- inhibit Na+ channels reducing Na+ reabsorption and K+ secretion
adverse effects of loop diuretics
- hyponatremia
- hypokalemia
- hypomagnesemia
- ototoxicity
- metabolic alkalosis
adverse effects of K+ sparing diuretics
- hyperkalemia
- metabolic acidosis
- gynecomastia (spironolactone)
- acute renal failure (triamterene + indomethacin)
- kidney stone (triamterene)
mechanism of hydralazine
Inhibits IP3-induced release of calcium from smooth muscle endoplasmic reticulum → arteriole vasodilation → reduces peripheral resistance –> increases cardiac output
mechanism of sacubitril-varsartan
- sacubitril is a neprilysin inhibitor –> prolongs BNP effects that antagonises RAAS (good) but neprilysin breaks down Ang II
- hence add on valsartan
hydralazine is used with what drug
isosorbide nitrate
due to hydralazine activating the baroreflex sympathetic activation
hydralazine (alone) is contraindicated in
coronary artery disease
mechanism of isosorbide mononitrate/dinitrate
- venodilation –> reduced preload
- arteriolar dilation –> reduced dilation
this decreases cardiac load and blood pressure
mechanism of cardiac glycosides
- inhibit Na+/K+ ATPase pump in cardiac myocytes –> lesser Na+ efflux, increase in intracellular Na+ concentration
- less Ca2+ efflux –> stronger systolic contraction
- increased cardiac output would mean
1. lesser carotid sinus firing –> less activation of SNS –> less afterload (because SNS causes vasoconstriction of peripheral vessels)
2. more renal blood flow –> less activation of RAAS –> less preload
Digoxin also reduces QT, ST and causes inversion of T. This increases parasympathetic activity and decreases AV conduction, increasing PR interval and decreasing ventricular rate → helpful for arrhythmias like AF
adverse effects of cardiac glycosides
more severe dysrhythmia like VF, AV block; GI effects like anorexia, nausea,vomiting; CNS effects like headache, fatigue, confusion, blurred vision